We are live on ! Find out more
WG

Winton Group Portfolio holdings

AUM $3.09B
1-Year Est. Return 40.4%
This Fund
S&P 500
This Quarter Est. Return
+21.95%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.72%
AUM
$1.39B
AUM Growth
-$1.69B
Cap. Flow
-$2.06B
Cap. Flow %
-148.56%
Top 10 Hldgs %
17%
Holding
1,625
New
174
Increased
68
Reduced
1,053
Closed
325

Sector Composition

Rank Sector Weight
1 Financials 16.52%
2 Consumer Discretionary 13.29%
3 Healthcare 12.02%
4 Industrials 11.54%
5 Technology 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGYS icon
576
Agilysys
AGYS
$3.02B
$735K 0.05%
19,144
-66,586
-78% -$2.21M
LXP icon
577
LXP Industrial Trust
LXP
$3.58B
$735K 0.05%
13,833
-58,012
-81% -$3.06M
AGIO icon
578
Agios Pharmaceuticals
AGIO
$1.95B
$733K 0.05%
16,908
-36,441
-68% -$1.44M
PNTG icon
579
Pennant Group
PNTG
$1.38B
$733K 0.05%
12,626
-8,302
-40% -$399K
TYL icon
580
Tyler Technologies
TYL
$13B
$733K 0.05%
1,680
-6,892
-80% -$2.84M
PRAH
581
DELISTED
PRA Health Sciences, Inc.
PRAH
$733K 0.05%
5,841
-10,515
-64% -$1.18M
INN
582
Summit Hotel Properties
INN
$670M
$732K 0.05%
+81,248
New +$601K
ADT icon
583
ADT
ADT
$5.49B
$730K 0.05%
92,978
-197,781
-68% -$1.55M
MET icon
584
MetLife
MET
$61.7B
$728K 0.05%
15,516
-42,525
-73% -$1.84M
AXNX
585
DELISTED
Axonics, Inc. Common Stock
AXNX
$728K 0.05%
14,586
-37,380
-72% -$1.76M
DORM icon
586
Dorman Products
DORM
$3.95B
$724K 0.05%
8,335
-17,545
-68% -$1.63M
IMKTA icon
587
Ingles Markets
IMKTA
$1.62B
$723K 0.05%
16,949
-1,880
-10% -$72.6K
GILD icon
588
Gilead Sciences
GILD
$165B
$722K 0.05%
12,397
-52,631
-81% -$3.18M
MU icon
589
Micron Technology
MU
$972B
$722K 0.05%
+9,597
New +$579K
CBRL icon
590
Cracker Barrel
CBRL
$1.25B
$721K 0.05%
5,467
-6,006
-52% -$773K
HST icon
591
Host Hotels & Resorts
HST
$15.5B
$721K 0.05%
49,278
-45,500
-48% -$589K
COO icon
592
Cooper Companies
COO
$14.9B
$720K 0.05%
7,924
-3,200
-29% -$275K
DRNA
593
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$720K 0.05%
32,676
-72,314
-69% -$1.59M
PDLI
594
DELISTED
PDL BioPharma, Inc.
PDLI
$720K 0.05%
291,360
-283,063
-49% -$689K
BMRN icon
595
BioMarin Pharmaceuticals
BMRN
$13.3B
$719K 0.05%
8,200
-24,574
-75% -$1.95M
WSBF icon
596
Waterstone Financial
WSBF
$370M
$718K 0.05%
38,129
-106,777
-74% -$1.87M
VLGEA icon
597
Village Super Market
VLGEA
$616M
$717K 0.05%
32,507
-40,623
-56% -$944K
TUP
598
DELISTED
Tupperware Brands Corporation
TUP
$714K 0.05%
22,042
-110,602
-83% -$3.26M
BBBY
599
DELISTED
Bed Bath & Beyond Inc
BBBY
$713K 0.05%
+40,158
New +$833K
SYY icon
600
Sysco
SYY
$40.1B
$710K 0.05%
+9,567
New +$658K

Similar funds

Winton Group's Q4 2020 Portfolio in Review

As of Q4 2020, Winton Group held 1,625 positions worth $1.39B, down 55% from $3.08B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Winton Group withdrew a net $2.06B in Q4 2020, closing 325 positions and reducing 1,053 holdings. Its most notable exit was Immunomedics Inc, an estimated $8.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Winton Group opened a new position in Stifel worth $4.52M.

  • Winton Group's largest Q4 2020 buy was Stifel: 134,360 shares worth $4.52M.
  • Winton Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2020, an estimated $12.4M increase.
  • Winton Group's biggest Q4 2020 reduction was Edwards Lifesciences, cutting an estimated $18.2M.
  • Winton Group fully exited Immunomedics Inc in Q4 2020, selling an estimated $8.1M.
  • Winton Group's ten largest holdings make up 17% of its $1.39B portfolio in Q4 2020.
  • Winton Group opened 174 new positions and closed 325 in Q4 2020.
  • Winton Group's portfolio value fell 55% quarter-over-quarter to $1.39B.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.